KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Equity Ratio (2019 - 2025)

GoodRx Holdings' Equity Ratio history spans 6 years, with the latest figure at 0.52 for Q4 2024.

  • For Q4 2024, Equity Ratio rose 8.86% year-over-year to 0.52; the TTM value through Dec 2024 reached 0.52, up 8.86%, while the annual FY2024 figure was 0.52, 8.86% up from the prior year.
  • Equity Ratio for Q4 2024 was 0.52 at GoodRx Holdings, up from 0.51 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.53 in Q2 2023 and bottomed at 0.43 in Q1 2024.
  • The 5-year median for Equity Ratio is 0.51 (2023), against an average of 0.5.
  • The largest annual shift saw Equity Ratio soared 117.21% in 2020 before it fell 15.47% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.48 in 2020, then increased by 6.91% to 0.52 in 2021, then fell by 1.84% to 0.51 in 2022, then decreased by 5.56% to 0.48 in 2023, then increased by 8.86% to 0.52 in 2024.
  • Per Business Quant, the three most recent readings for GDRX's Equity Ratio are 0.52 (Q4 2024), 0.51 (Q3 2024), and 0.45 (Q2 2024).